(PhysOrg.com) -- Infections following treatment in clinics, retirement homes, and long-term care facilities are a grave problem for patients, and resistant germs can be particularly devastating.
“High infection rates are in particular observed related to implants, catheters, and stents,” reports Karl Gademann, “those for urinary catheters mounting up to 30 % per week!” In cooperation with his team at the Swiss Federal Institute of Technology in Lausanne, he has developed a process for coating surfaces with an antimicrobial layer. As reported in the journal Angewandte Chemie, their system is based on hybrid molecules derived from various natural products.
For a patient, the results are particularly grave if an infection occurs in an implant. Usually, replacement of the affected part is the only possible treatment. “One particularly attractive approach is the application of antibiotics directly on the material,” says Gademann. To test their idea, the team from Lausanne chose to use natural product hybrids: biologically active fragments of various natural products are coupled to combine two different modes of action.
The hybrid produced by Gademann’s team is made of three parts: two natural products are coupled by means of a polymer bridge. The first substance is anachelin, an iron transporter (siderophore) from cyanobacteria. Anachelin strongly and selectively binds metal oxides.
The majority of implants are made from a metal oxide: highly biocompatible titanium dioxide. Anachelin fixes the hybrid firmly to the surface of the implant. The second natural product is the antibiotic vancomycin, which disrupts the biosynthesis of cell walls and thus stops bacterial growth. The coupling component is polyethylene glycol, a chemically inert, nontoxic polymer. It also assures that dead bacteria and cell components cannot bind to the surface.
The hybrid can be applied to titanium dioxide components in a simple dunking procedure. “We were able to demonstrate that our hybrid firmly attaches to titanium dioxide surfaces and effectively hinders infection with Bacillus subtilis as well as the attachment of cellular material,” says Gademann.
Citation: Karl Gademann, Antimicrobial Surfaces through Natural Product Hybrids, Angewandte Chemie International Edition, doi: 10.1002/anie.200801570
Provided by Wiley
Related stories:
Tahitian vanilla originated in Maya forests
The origin of the Tahitian vanilla orchid, whose cured fruit is the source of the rare and highly esteemed gourmet French Polynesian spice, has long eluded botanists. Known by the scientific name
Vanilla tahitensis, Tahitian vanilla is found to exist only in cultivation; natural, wild populations of the orchid have never been encountered.
Mileage from megawatts: Study finds enough electric capacity to 'fill up' plug-in vehicles across much of the nation
If all the cars and light trucks in the nation switched from oil to electrons, idle capacity in the existing electric power system could generate most of the electricity consumed by plug-in hybrid electric vehicles. A new study for the Department of Energy finds that "off-peak" electricity production and transmission capacity could fuel 84 percent of the country's 220 million vehicles if they were plug-in hybrid electrics.
Bacteria to run our cars, warm our homes
The United States Department of Energy has devoted $1.6 million to sequencing the DNA of six photosynthetic bacteria that Washington University in St. Louis biologists will examine for their potential as one of the next great sources of biofuel that can run our cars and warm our houses.
Reining in carbon dioxide levels imperative but possible
Implementing a plan to keep rising carbon dioxide levels from reaching potentially dangerous levels could cost less than 1 percent of gross world product as of 2050, a cost that is well within reach of developed and developing nations alike. Moreover, without simultaneous progress in the way energy is found, transformed, transported and used, the world is in danger of facing a severe energy crisis sometime within the next century. Those are the conclusions of a report by Klaus S. Lackner and Jeffrey D. Sachs of The Earth Institute that appears in the most recent issue of Brookings Papers on Economic Activity published by the Brookings Institute.
Sony's World's Smallest HD Consumer Camcorder
Sony announced the world's smallest and lightest high definition consumer camcorder with full HD resolution based on HDV 1080i.
The ultra-compact HDR-HC1 Handycam camcorder fits comfortably in your hand, while delivering high-definition picture quality and lighting detail on both video and digital still images.
This camcorder's introduction is in response to the growing demand for HDTV. With more broadcasters transmitting high-definition content, the demand for HD has been steadily increasing. In fact, the Consumer Electronics Association estimates that nearly 15 million HDTV sets will be in US households by the end of 2005.
New bone implant technology using techniques normally used to make catalytic converters
A method of producing synthetic bone, using techniques normally used to make catalytic converters for cars, is being developed by researchers at WMG at the University of Warwick.
Mini heart attacks lessen damage from major ones
Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published today in the journal
Cardiovascular Research. The new mechanism points to how future drugs could provide protection ahead of heart attacks and strokes for those at highest risk. In the nearer term, the work may help to prevent damage caused as U.S. heart surgeons temporarily cut off blood flow 450,000 times each year to perform coronary artery bypass graft surgeries. Lastly, the discoveries hold clues to the value of the Mediterranean diet beyond red wine.
Scientists teach enzyme to make synthetic heparin in more varieties
Scientists at the University of North Carolina at Chapel Hill have learned to customize a key human enzyme responsible for producing heparin, opening the door to a more effective synthetic anticoagulant as well as treatments for other conditions.